about
Estimating cell depth from somatic mutationsCTLs respond with activation and granule secretion when serving as targets for T-cell recognitionEmbryonic pig pancreatic tissue transplantation for the treatment of diabetesReconstruction of cell lineage trees in miceNanoscale increases in CD2-CD48-mediated intermembrane spacing decrease adhesion and reorganize the immunological synapseEnhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control.Embryonic porcine skin precursors can successfully develop into integrated skin without teratoma formation posttransplantation in nude mouse modelThe role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation.Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells.Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor.Haploidentical stem cell transplantation in leukemia.Transplants across human leukocyte antigen barriers.Haploidentical 'megadose' stem cell transplantation in acute leukemia: recommendations for a protocol agreed upon at the Perugia and Chicago meetings.A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cellsMurine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.Crossing the HLA barriers.Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells.Expression of peanut agglutinin receptors on virus-induced preleukemic cells in mice.Separation of antibody helper and antibody suppressor human T cells by using soybean agglutininFetal pancreas as a source for islet transplantation: sweet promise and current challengesFrom 'megadose' haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantation.Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model.Haploidentical bone marrow transplantation in primary immune deficiency: stem cell selection and manipulation.Megadose stem cell administration as a route to mixed chimerism.Haploidentical hematopoietic stem cell transplantation: state of art.The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.The evolution of T-cell depletion in haploidentical stem-cell transplantation.Novel immunoregulatory role of perforin-positive dendritic cells.Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up."Designed" grafts for HLA-haploidentical stem cell transplantation.Bone marrow transplantation--an expanding approach to treatment of many diseases.Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells.Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells.Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo.Hematopoietic stem cell transplantation for cancer therapy.Purification in large amounts of beta-D-galactoside-binding lectins from a murine thymic epithelial cell line.Next generation HLA-haploidentical HSCT.The use of donor-derived veto cells in hematopoietic stem cell transplantation.Haploidentical Family Donor Transplantation: At the Crossroads of a Changing Paradigm.
P50
Q21145377-CB45CBFA-5694-40C6-9535-9DB353FFD7AAQ24629828-AAE136DA-3785-4031-8B44-1B72D12C9665Q28768559-D7484B70-2930-4451-A6BC-CB18040ACA44Q33327362-5C836764-0F8B-4362-828F-BC306FDE9826Q33372998-8E66C228-E2B6-4105-83BC-D890752C24F1Q33520217-1FA7DD2C-152E-4FA9-A2DD-58DC260CD4E8Q33525554-63404D93-FBD2-4F0D-BC8F-12F788A8C6DBQ33661926-9278B3C9-9CA0-4B4A-AB60-B7827D9BA3D7Q33722672-DFA381C6-7F11-48EC-B59E-FD593C49BF49Q34046823-BE2453E4-C84B-4AA2-826E-2CD522C65D87Q34458148-5CF81C89-B095-4AE2-A8AB-574A2132D212Q34499742-6CB18D24-C85B-4F94-8F04-65C37F883896Q34565044-48336A0E-47FC-45E1-B904-7B5C6014D81BQ35743874-38A7BCBD-F87E-4941-B3EF-0B9218FF55A1Q35743914-4A3B18F4-AC8E-495C-B765-6C993D138097Q35940365-2A0524F4-C62F-421D-9DA2-352CD495B26BQ36164487-6AD20BD1-6948-42A9-A28C-0D91B8526B78Q36364932-A8C74F06-E5BD-406B-A930-4DA9F1F3956CQ36416376-04E8B897-3B90-4E86-B06B-0049184031EFQ36795974-831785FE-F4F4-49BD-BFFF-FC56DEFE86BAQ36991272-BF6359B7-414B-4B8A-87FE-CB26D6E1E625Q37208835-E8FA2784-8771-4A76-8D62-150DFE040C77Q37828738-7DAEC69C-394C-4515-93CB-0A7FD4B9C8DAQ38218154-83EDABD1-B457-4E8C-8794-C0364942DDF0Q38514481-34F900A5-8B4E-44E2-B233-F32BD069D679Q38514485-0920D27F-A5E2-45E0-845A-D8726DF53739Q38673780-48558A2E-3EE5-48A0-88E9-70B986766186Q38941653-459E3D84-9611-45DD-A31B-BE498CD908C5Q39202778-D2E61FAB-F2DA-4894-BA96-96A188E1E480Q39289225-CD08C5D7-0F35-457A-972A-B81642C6B0DFQ40162816-4AAF93E6-09B4-4667-9831-44E802DF3B39Q40395995-2264866D-FB91-4F96-B424-6326591720D9Q40404351-02A33766-4D07-40E7-B0CA-2459294D0222Q40780186-2AA767DA-5503-4585-A61F-B566B3F77917Q40882583-D63E20EF-7EFA-42C1-9C2C-4789923BCB3EQ40952510-3FE1E294-52A6-4EB9-9C55-2D3359D894A3Q41678772-2AE157AC-3B1F-42C7-AB32-846B3D28D68FQ41697436-AB1A1D35-ACB8-43E3-95C5-68DA1DD33D78Q42144054-259F801E-3A79-4376-9A49-A8DA109DB7E7Q42703019-973E1BB7-0832-474B-971E-062275A5DA7B
P50
description
researcher ORCID ID = 0000-0002-3354-6945
@en
name
Yair Reisner
@ast
Yair Reisner
@en
Yair Reisner
@es
Yair Reisner
@nl
type
label
Yair Reisner
@ast
Yair Reisner
@en
Yair Reisner
@es
Yair Reisner
@nl
prefLabel
Yair Reisner
@ast
Yair Reisner
@en
Yair Reisner
@es
Yair Reisner
@nl
P1153
7006335417
P31
P496
0000-0002-3354-6945